Skip to main content
GLUE logo

GLUE · Monte Rosa Therapeutics, Inc. · Analyst Estimates

Track GLUE — free
$10.27 -0.23 (-2.19%)
Market Cap
$1.00B
Shares
85.31M
Volume · Oct 5 1.75M Avg daily vol (3M) 1.3M

Analyst Estimates

Compare analyst forecasts for Monte Rosa Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-05 14:51 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.02
-1.42808
-0.41463
—
-1.56638
-1.59857
-1.44495
-1.59143
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
0
1
2
3
Revenue
USD
Publication date not stated
13200000
67428000
190848000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.15
-1.94748
0.24018
—
-1.87569
-1.81429
-1.87426
-1.81429
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
0
53934000
286272000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.56
-0.22482
0.10143
—
-0.34694
-0.38
-0.22694
-0.38
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
0
0
2
2
Revenue
USD
Publication date not stated
0
31500000
67000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.59
-0.34973
0.38215
—
-0.36684
-0.41143
-0.36541
-0.41143
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
1
0
2
1
Revenue
USD
Publication date not stated
0
23180250
111000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —
Key facts CIK 1826457 CUSIP 61225M102 13F (30d) 2 filings 2 filers Visit website Investor relations